• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:朱益,尹超云,张进,陶政.丹参酮IIA磺酸钠不同给药时段对其内皮保护作用的影响[J].中国现代应用药学,2021,38(2):161-166.
ZHU Yi,YIN Chaoyun,ZHANG Jin,TAO Zheng.Influence of Different Administration Timepoints on the Endothelial Protective Effects of Sodium Tanshinone IIA Sulfonate[J].Chin J Mod Appl Pharm(中国现代应用药学),2021,38(2):161-166.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3911次   下载 2033 本文二维码信息
码上扫一扫!
分享到: 微信 更多
丹参酮IIA磺酸钠不同给药时段对其内皮保护作用的影响
朱益1, 尹超云2, 张进3, 陶政2
1.镇江市第一人民医院检验科, 江苏 镇江 212000;2.江苏大学附属医院, 血管外科, 江苏 镇江 212000;3.江苏大学附属医院, 普外科, 江苏 镇江 212000
摘要:
目的 研究不同给药时段对丹参酮IIA磺酸钠(sodium tanshinone IIA sulfonate,STS)内皮保护作用的影响。方法 将人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVEC)分组刺激,分为5组: DMEM组、脂多糖(lipopolysaccharide,LPS)处理组、STS预处理+LPS组、STS+LPS共处理组、STS后处理+LPS组。其中,LPS终浓度为1 μg·mL-1,STS终浓度为25 μg·mL-1,LPS刺激时间为12 h。处理完成后,CCK-8法测定HUVEC活力; ELISA检测细胞培养上清中炎症因子白细胞介素-1β(interleukin-1β,IL-1β)的蛋白浓度; Western blotting检测细胞裂解液中核因子κB (nuclear factor κB,NF-κB)的蛋白水平;划痕试验检测HUVEC的迁移能力;光镜观察细胞凋亡状态,并用Western blotting检测凋亡相关分子cleaved caspase-3和cleaved caspase-9的蛋白水平。结果 与DMEM组相比,LPS处理后HUVEC增殖活力减低;IL-1β和NF-κB蛋白水平增高;细胞迁移能力降低、细胞凋亡增加并伴有cleaved caspase-3和cleaved caspase-9蛋白水平的升高(P<0.05); STS处理能够部分逆转LPS引起的上述现象,其中以STS预处理的效果最为明显,而STS后处理的效果相对较弱。结论 STS预处理、共处理和后处理均能部分抑制LPS诱导的HUVEC功能异常和凋亡,且以预处理时的效果最为明显。
关键词:  丹参酮ⅡA磺酸钠  给药时段  人脐静脉内皮细胞  脂多糖  内皮功能异常  cleaved caspase-3  cleaved caspase-9
DOI:10.13748/j.cnki.issn1007-7693.2021.02.006
分类号:R285.5
基金项目:江苏省自然科学基金青年基金项目(BK20130474)
Influence of Different Administration Timepoints on the Endothelial Protective Effects of Sodium Tanshinone IIA Sulfonate
ZHU Yi1, YIN Chaoyun2, ZHANG Jin3, TAO Zheng2
1.Department of Clinical Laboratory, Zhenjiang First People's Hospital, Zhenjiang 212000, China;2.Affiliated Hospital of Jiangsu University, Department of Vascular Surgery, Zhenjiang 212000, China;3.Affiliated Hospital of Jiangsu University, Department of General Surgery, Zhenjiang 212000, China
Abstract:
OBJECTIVE To investigate the influence of different administration timepoints on the endothelial protective effects of sodium tanshinone II A sulfonate(STS). METHODS Human umbilical vein endothelial cells(HUVEC) were divided into five groups, individually stimulated, including DMEM group, lipopolysaccharide(LPS) group, STS pre-treatment+LPS group, STS co-treatment+LPS group, STS post-treatment+LPS group. The final concentration of LPS in the experiment was 1 μg·mL-1, and that of STS was 25 μg·mL-1, LPS stimulation time was 12 h. After that, HUVEC viability was determined by CCK-8 assay. The protein concentration of inflammatory cytokine interleukin-1β(IL-1β) in HUVEC culture supernatant was detected by ELISA. The protein levels of nuclear factor κB(NF-κB) in HUVEC lysate were detected by Western blotting. The migration capacity of HUVEC was detected by wound-healing test. HUVEC apoptosis was observed under an optical microscopy, and the expression of apoptosis-related proteins including cleaved caspase-3 and cleaved caspase-9 were detected by Western blotting. RESULTS Compared with DMEM group, after LPS treatment, HUVEC cell viability was decreased; IL-1β and NF-κB protein expression increased; migration capacity impaired; increased apoptosis with the higher protein expression of cleaved caspase-3 and cleaved caspase-9(P<0.05). STS treatments could partially reverse these LPS-induced phenomena, among which the STS pre-treatment was most effective, while the STS post-treatment was with relative lower efficacy. CONCLUSION STS pre-treatment, co-treatment and post-treatment can partially reverse LPS-induced HUVEC dysfunction and apoptosis, among which the STS pre-treatment is most effective.
Key words:  sodium tanshinone IIA sulfonate  administration timepoints  human umbilical vein endothelial cells  LPS  endothelial dysfunction  cleaved caspase-3  cleaved caspase-9
扫一扫关注本刊微信